Bjørn Steen Skålhegg
Founder at Spermatech AS
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Tuva Holt Hereng | M | - |
Spermatech AS
 Spermatech AS Pharmaceuticals: MajorHealth Technology Spermatech AS develops a non-hormonal male contraception pill. It operates as an early drug development company that identifies small molecules which can be developed into non-hormonal male contraceptives. The firm develops a test set-up using living human sperm cells. The company was founded by Eirik Næss-Ulseth and Bjorn Steen Skalhegg in 2002 and is headquartered in Oslo, Norway.
University of Oslo
| 17 years |
| Inger Berg Ørstavik | M | 50 |
University of Oslo
| 4 years |
| Tore Jahnsen | M | 70 |
Spermatech AS
Spermatech AS Pharmaceuticals: MajorHealth Technology Spermatech AS develops a non-hormonal male contraception pill. It operates as an early drug development company that identifies small molecules which can be developed into non-hormonal male contraceptives. The firm develops a test set-up using living human sperm cells. The company was founded by Eirik Næss-Ulseth and Bjorn Steen Skalhegg in 2002 and is headquartered in Oslo, Norway.
University of Oslo
| 32 years |
| Eirik Næss-Ulseth | M | 68 |
Spermatech AS
Spermatech AS Pharmaceuticals: MajorHealth Technology Spermatech AS develops a non-hormonal male contraception pill. It operates as an early drug development company that identifies small molecules which can be developed into non-hormonal male contraceptives. The firm develops a test set-up using living human sperm cells. The company was founded by Eirik Næss-Ulseth and Bjorn Steen Skalhegg in 2002 and is headquartered in Oslo, Norway. | 22 years |
| Inger Sandlie | M | 71 |
University of Oslo
| - |
| Erlend Bremertun Smeland | M | 69 |
University of Oslo
| - |
| Kjetil Storesletten | M | 57 |
University of Oslo
| 12 years |
| Sigurd Ørstavik | M | 55 |
Spermatech AS
Spermatech AS Pharmaceuticals: MajorHealth Technology Spermatech AS develops a non-hormonal male contraception pill. It operates as an early drug development company that identifies small molecules which can be developed into non-hormonal male contraceptives. The firm develops a test set-up using living human sperm cells. The company was founded by Eirik Næss-Ulseth and Bjorn Steen Skalhegg in 2002 and is headquartered in Oslo, Norway. | - |
| Ken Roger Rosendal | M | 52 |
Spermatech AS
Spermatech AS Pharmaceuticals: MajorHealth Technology Spermatech AS develops a non-hormonal male contraception pill. It operates as an early drug development company that identifies small molecules which can be developed into non-hormonal male contraceptives. The firm develops a test set-up using living human sperm cells. The company was founded by Eirik Næss-Ulseth and Bjorn Steen Skalhegg in 2002 and is headquartered in Oslo, Norway. | - |
| Are Magnus Bruaset | M | - |
University of Oslo
| - |
| Øyvind Sverre Bruland | M | 72 |
University of Oslo
| - |
| Aslak Tveito | M | 63 |
University of Oslo
| - |
| Lars Groth | M | 76 |
University of Oslo
| - |
| Giuditta Cordero-Moss | M | 61 |
University of Oslo
| 25 years |
| Peter A. M. Maassen | M | - |
University of Oslo
| - |
| Egil Myklebust | M | 82 |
University of Oslo
| - |
| Eirik Frantzen | M | 56 |
University of Oslo
| - |
| Karen Helene Ulltveit-Moe | M | 56 |
University of Oslo
| - |
| Jo Erik Johnsrud Klaveness | M | 71 |
University of Oslo
| - |
| Frank Larsen | M | - |
University of Oslo
| - |
| Kjetil Taskén | M | 59 |
University of Oslo
| 23 years |
| Staale Petter Lyngstadaas | M | 62 |
University of Oslo
| - |
| Harald Carlsen | M | 56 |
University of Oslo
| - |
| Rune Blomhoff | M | 69 |
University of Oslo
| - |
| Asbjørn Rødseth | M | 73 |
University of Oslo
| - |
| Lars Skattebøl | M | - |
University of Oslo
| 54 years |
| Jon Steen Petersen | M | 77 |
University of Oslo
| - |
| Haakon Bryhni | M | 56 |
University of Oslo
| - |
| Boel Flodgren | M | 82 |
University of Oslo
| - |
| Gunnar Hvammen | M | 61 |
Spermatech AS
Spermatech AS Pharmaceuticals: MajorHealth Technology Spermatech AS develops a non-hormonal male contraception pill. It operates as an early drug development company that identifies small molecules which can be developed into non-hormonal male contraceptives. The firm develops a test set-up using living human sperm cells. The company was founded by Eirik Næss-Ulseth and Bjorn Steen Skalhegg in 2002 and is headquartered in Oslo, Norway. | - |
| Leiv Jacob Gelius | M | 68 |
University of Oslo
| - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Daniel Ras-Vidal | M | - |
University of Oslo
| 4 years |
| Lars Henrik Høie | M | 67 |
University of Oslo
| 3 years |
| Henrik Hareide Nilsen | M | - |
University of Oslo
| 1 years |
| Fabio Buonsanti | M | - |
University of Oslo
| 1 years |
| Marianne Thorsdal | F | 61 |
University of Oslo
| 4 years |
| Bjørn Petter Lindhom | M | - |
University of Oslo
| 1 years |
| Andreas Kveil Slettvoll | M | - |
University of Oslo
| 5 years |
| Jens Bjørheim | M | - |
University of Oslo
| 3 years |
| Linn E. Drejer-Dølvik | F | - |
University of Oslo
| 1 years |
| Ambalathil Line Engelmann-Kokkim | F | - |
University of Oslo
| 5 years |
| Arna Vikanes Sørheim Murray | F | - |
University of Oslo
| 3 years |
| Mette Husbyn | M | - |
University of Oslo
| 3 years |
| Katinka Wikborg | F | - |
University of Oslo
| 1 years |
| Nils Holger Koefoed | M | - |
University of Oslo
| 1 years |
| Karoline W. Schjetne | M | - |
University of Oslo
| 3 years |
| Line Johnsen | M | - |
University of Oslo
| 3 years |
| John Ole Ruch | M | 38 |
University of Oslo
| 3 years |
| Mason M. Darabi | M | 40 |
University of Oslo
| - |
| Kari Furu | M | 44 |
University of Oslo
| 3 years |
| Georg Beiske | M | - |
University of Oslo
| 6 years |
| Jayden Basha | M | - |
University of Oslo
| - |
| Hanne Ringnes Sanne | F | - |
University of Oslo
| 3 years |
| Kristine Larneng | F | 42 |
University of Oslo
| 6 years |
| Runar Wiik | M | 46 |
University of Oslo
| 3 years |
| Håkon Wium Lie | M | - |
University of Oslo
| 3 years |
| Ingunn Carelius | M | - |
University of Oslo
| 1 years |
| Hanne Harlem | F | 60 |
University of Oslo
| 3 years |
| Gulden Tobias Dahl | M | - |
University of Oslo
| 3 years |
| Tarik Cicic | M | - |
University of Oslo
| 3 years |
| Marianne Heien Blystad | F | 66 |
University of Oslo
| 3 years |
| Agnete Brunsvik Fredriksen | M | 47 |
University of Oslo
| 3 years |
| Viktor Sigurd Wold Eide | M | 53 |
University of Oslo
| 3 years |
| Bettina Banoun | M | 52 |
University of Oslo
| 3 years |
| Torild Skogsholm | F | 65 |
University of Oslo
| 4 years |
| Daniel Kjørberg Siraj | M | 49 |
University of Oslo
| 3 years |
| Britt Kjelleberg | F | 46 |
University of Oslo
| 3 years |
| Oyvind Greaker Bjorndal | M | - |
University of Oslo
| 5 years |
| Inga Kaasen | M | 66 |
University of Oslo
| 3 years |
| Mari Rege | M | 50 |
University of Oslo
| 3 years |
| Anine Tennøe Ramm | F | 46 |
University of Oslo
| 3 years |
| Anne Kristin Holmeide | M | 56 |
University of Oslo
| 3 years |
| Burkhard Fleckenstein | M | - |
University of Oslo
| 5 years |
| Henrik Inadomi | M | - |
University of Oslo
| 4 years |
| Olav Liseth | M | - |
University of Oslo
| 1 years |
| Kristin Hellebust | F | - |
University of Oslo
| 1 years |
| Jeannele M'Bembath | F | - |
University of Oslo
| 1 years |
| Amol Judge | M | - |
University of Oslo
| 3 years |
| Kristin Isdal Selmer | F | - |
University of Oslo
| 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Norway | 79 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Bjørn Steen Skålhegg
- Personal Network
